Anti-cd47 antibody for combined treatment of blood tumor
US-2024269278-A1 · Aug 15, 2024 · US
Framework selection
US9249232B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9249232-B2 |
| Application number | US-30705107-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 26, 2007 |
| Priority date | Jul 3, 2006 |
| Publication date | Feb 2, 2016 |
| Grant date | Feb 2, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to improved methods for the selection of appropriate human acceptor framework regions for non-human (donor) antibodies and methods for obtaining humanized antibodies of high affinity using such acceptor frameworks.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for obtaining at least one humanized antibody with specificity for a selected antigen comprising: (a) providing multiple donor antibody V H and/or V L region sequences each with specificity for the selected antigen; (b) selecting for each donor region sequence of step (a), an appropriate human V H region acceptor framework sequence and/or an appropriate human V L region acceptor framework sequence, wherein selection of the human acceptor…
Assignees
Inventors
Classifications
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
- C07K16/464Primary
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9249232B2 cover?
- The present invention relates to improved methods for the selection of appropriate human acceptor framework regions for non-human (donor) antibodies and methods for obtaining humanized antibodies of high affinity using such acceptor frameworks.
- Who is the assignee on this patent?
- Adams Ralph, Lawson Alastair David Griffiths, Popplewell Andrew George, and 2 more
- What technology area does this patent fall under?
- Primary CPC classification C07K16/464. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Feb 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).